|
October 18, 2016
|
Highlights from AMCP |
|
More payers are using oncology pathways, but are they working? Read more. |
|
While healthcare has flown under the radar for much of this election season, it's a topic that was not ignored at the AMCP Nexus. Read more. |
|
Analysis from Prime shows that improved persistency is key in RA treatments. Read more. |
|
MCOs are going to have to step up their efforts to impact the growing opioid epidemic in this country. Read more. |
Top content
|
|
|
We welcome your feedback!
Please send your comments to:
Aubrey Westgate
Executive Editor
Managed Healthcare Executive
[email protected] |
DISCLAIMER:
This information has been independently developed and provided by the editors of Managed Healthcare Executive. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular. |
|
